| Home | E-Submission | Sitemap | Editorial Office |  
Journal of Korean Neurosurgical Society > Epub ahead of print

doi: https://doi.org/10.3340/jkns.2021.0265    [Epub ahead of print]
Surgical Treatment for Trigeminal Neuralgia
Chang Kyu Park , Bong Jin Park
Department of Neurosurgery, College of Medicine, Kyung Hee University, Seoul, Korea
Correspondence  Bong Jin Park ,Tel: +82-2-958-8385, Fax: +82-2-958-8380, Email: hyunsong@khmc.or.kr
Received: November 9, 2021; Revised: January 19, 2022   Accepted: February 16, 2022.  Published online: April 18, 2022.
Various treatments for trigeminal neuralgia (TN) are known to yield initial satisfactory results; however, the surgical treatment has excellent long-term outcomes and a low recurrence rate. Surgical treatment addresses the challenge of vascular compression, which accounts for 85% of the causes of TN. As for surgical treatment for TN, microvascular decompression (MVD) has become the surgical treatment of choice after Peter J. Jannetta reported the results of MVD surgery in 1996. Since then, many studies have reported a success rate of over 90% for the initial surgical treatment. Most MVDs aim to separate (decompress) the culprit vessel from the trigeminal nerve. To increase the success rate of surgery, accurate indications for MVD and management of the offender vessels without complications are critical. In addition, if there is no vascular compression, partial sensory rhizotomy or internal neurolysis can be performed to improve surgical outcomes.
Key Words: Trigeminal neuralgia · Microsurgery · Rhizotomy · Microvasclar decompression · Neurosurgical procedures
Editorial Office
1F, 18, Heolleung-ro 569-gil, Gangnam-gu, Seoul, Republic of Korea
TEL: +82-2-525-7552   FAX: +82-2-525-7554   E-mail: kns61@neurosurgery.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Neurosurgical Society.                 Developed in M2PI
Close layer
prev next